Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | SCN1A | P35498 | 3/20 | 0.40 |
| ▸ | SCN2A | Q99250 | 3/20 | 0.40 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HTR2A | P28223 | 2/20 | 0.40 |
| ▸ | HRH1 | P35367 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | HRH2 | P25021 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17305906 | 0.88 | SLC6A2 (0.46) | ADRA2AADRA2BADRA2CSCN1ASCN2A | |
| SCHEMBL8185999 | 0.83 | SCN1A (0.58) | ADRA2AADRA2BSCN1ASCN2ASCN3A | |
| SCHEMBL18309269 | 0.83 | SCN1A (0.40) | ADRA2AADRA2BSCN1ASCN2ASCN3A | |
| SCHEMBL431888 | 0.81 | SCN1A (0.41) | ADRA2AADRA2BSCN1ASCN2ASCN3A | |
| SCHEMBL2701953 | 0.81 | HTT (0.42) | ADRA2AADRA2BADRA2CSCN1ASCN2A | |
| SCHEMBL10650273 | 0.80 | HTR2A (0.45) | ADRA2AADRA2BSCN1ASCN2ASCN3A | |
| SCHEMBL10652751 | 0.80 | TAAR1 (0.41) | ADRA2AADRA2CLMNAHTTAOC3 | |
| SCHEMBL9871371 | 0.79 | TAAR1 (0.43) | ADRA2AADRA2BSCN1ASCN2ASCN3A | |
| SCHEMBL97126 | 0.79 | HCAR2 (0.41) | ADRA2AADRA2BSCN1ASCN2ASCN3A | |
| SCHEMBL97127 | 0.79 | TRPA1 (0.44) | ADRA2AADRA2BADRA2CSCN1ASCN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | claimed |
| US-11806448-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2023-11-07 | — | — | US | claimed |
| EP-3006547-B1 | FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED | SHISEIDO CO LTD (JP) | 2019-10-30 | — | — | EP | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-20160106637-A1 | FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED | SHISEIDO COMPANY, LTD. (JP) | 2016-04-21 | — | — | US | claimed |
| EP-3006547-A1 | FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED | Shiseido Company Ltd. (JP) | 2016-04-13 | — | — | EP | claimed |
| CN-105452429-A | Fragrance-containing capsule and cosmetic in which said capsules are blended | SHISEIDO CO LTD | 2016-03-30 | — | — | CN | claimed |
| EP-1737937-B1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2013-06-12 | — | — | EP | claimed |
| EP-2072083-B1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | SYMRISE AG (DE) | 2012-02-15 | — | — | EP | claimed |
| US-20100247475-A1 | BETA-GLUCURONIDASE INHIBITOR | KAO CORPORATION (JP) | 2010-09-30 | — | — | US | claimed |
| WO-2005103214-A2 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2005-11-03 | — | — | WO | claimed |
| WO-2005004825-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | claimed |
| CN-1163217-C | Perfume composition | 国际调研有限公司 | 2004-08-25 | — | — | CN | claimed |
| US-6780835-B2 | DEODORANT FOR TREATING TEXTILES INCORPORATING SPANDEX | QUEST INTERNATIONAL B.V. (NL) | 2004-08-24 | — | — | US | claimed |
| EP-1029032-B1 | LAUNDRY TREATMENT PRODUCTS FOR SPANDEX CONTAINING FABRICS | UNILEVER PLC (GB) | 2004-03-03 | — | — | EP | claimed |
| US-20040033912-A1 | Composition for hard article surface cleaning liquid | TAKASAGO INTERNATIONAL CORPORATION | 2004-02-19 | — | — | US | claimed |
| CN-1275075-A | Perfume composition | QUEST INT (NL) | 2000-11-29 | — | — | CN | claimed |
| WO-1999057233-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 1999-11-11 | — | — | WO | claimed |
| EP-0596493-B1 | Fragrant peracetic acid-containing oxidizing composition | NIPPON PEROXIDE CO LTD (JP) | 1999-02-03 | — | — | EP | claimed |
| US-5554588-A | IN WHICH AT LEAST HALF COMPRISES ETHERS, AROMATIC METHYL KETONES, ALCOHOLS, ESTERS AND SALICYLATES; DEODORANTS AND ACCEPTABLE FRAGRANCE | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1996-09-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100247475-A1 | BETA-GLUCURONIDASE INHIBITOR | GUSB, GAA, GANAB | ADRA2A 2878/4885ADRA2B 2549/4885ADRA2C 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.